CEO Andrew Dudum was paid $22,958,907 in fiscal year 2025, ↓ down 6.7% from fiscal year 2024, the 84th percentile of its disclosed peer group (SEC filing 0001773751-26-000060 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$60,869,746 Mohamed Elshenawy total, FY2025 Chief Technology Officer — highest-paid officer; CEO Andrew Dudum: $22,958,907 | 84th CEO (Andrew Dudum) pay percentile vs peers | 272:1 CEO-to-median pay ratio | 99.26% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
HIMS's next annual pay disclosure, estimated May 1, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Mohamed Elshenawy | $375,000 | $3,000,000 | $57,216,276 | $0 | $278,470 | $0 | $0 | $60,869,746 |
| Chief Technology Officer | ||||||||
| Andrew Dudum | 494,792 | 0 | 10,635,352 | 11,000,000 | 585,763 | 0 | 243,000 | 22,958,907 |
| Chief Executive Officer and Chairman | ||||||||
| Nader Kabbani | 227,273 | 1,000,000 | 13,486,199 | 0 | 0 | 0 | 148,833 | 14,862,305 |
| Former Chief Operating Officer | ||||||||
| Yemi Okupe | 530,875 | 0 | 7,473,689 | 0 | 376,763 | 0 | 17,481 | 8,398,808 |
| Chief Financial Officer | ||||||||
| Melissa Baird | 341,292 | 0 | 8,048,579 | 0 | 0 | 0 | 3,000 | 8,392,871 |
| Former Chief Operating Officer | ||||||||
| Mike Chi | 485,000 | 0 | 6,898,799 | 0 | 340,914 | 0 | 3,000 | 7,727,713 |
| Chief Operating Officer (previously Chief Commercial Officer) | ||||||||
| Soleil Boughton | 464,375 | 0 | 4,024,269 | 0 | 305,065 | 0 | 3,000 | 4,796,709 |
| Chief Legal Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Mohamed Elshenawy | $60,869,746 | — | — | — |
| Andrew Dudum | 22,958,907 | 24,609,077 | 14,401,411 | ↓ −1,650,170 |
| Nader Kabbani | 14,862,305 | — | — | — |
| Yemi Okupe | 8,398,808 | 8,196,173 | 7,432,394 | ↑ +202,635 |
| Melissa Baird | 8,392,871 | 9,083,971 | 6,765,760 | ↓ −691,100 |
| Mike Chi | 7,727,713 | 7,008,181 | 6,709,160 | ↑ +719,532 |
| Soleil Boughton | 4,796,709 | 4,673,336 | 5,212,071 | ↑ +123,373 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Hims & Hers Health's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper HIMS reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses HIMS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named HIMS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Andrea Perez | Independent Director | $241,931 |
| Anja Manuel | Independent Director | $240,931 |
| Christiane Pendarvis | Former director (through FY2025) | $236,931 |
| Christopher Payne | Independent Director | $246,079 |
| David Wells | Lead Independent Director | $274,579 |
| Deb Autor | Independent Director | $305,931 |
| Delos Cosgrove | Independent Director | $226,931 |
| Kåre Schultz | Independent Director | $230,931 |
| Kofi Amoo-Gottfried | Independent Director | — |
| Patrick Carroll | Former director (through FY2025) | $226,931 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | $24 | $187,916 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | A | 7,950 | 5 | 39,830 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-20 | — | 2,039 | — | — | 3 insiders, 3 accrual rows | ||
| David Wells | Director | 2026-05-26 | A | 48,400 | 24 | 1,172,974 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-15 | — | 3,431 | — | — | 4 insiders, 4 accrual rows | ||
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 47,699 | 30 | 1,439,079 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 11,756 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 6,183 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 23,315 | 30 | 703,414 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 11,483 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,334 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 39,541 | 30 | 1,192,952 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 25,926 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 15,396 | 30 | 464,497 | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 647 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 435 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-15 | A | 957 | — | — | RSU | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 23,513 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 259,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 151,534 | 30 | 4,571,781 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | A | 282,597 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 19,150 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 35,446 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 85,632 | 30 | 2,583,517 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | A | 154,991 | — | — | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 3,879 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,344 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,065 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 2,291 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 5,870 | 30 | 177,098 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | A | 15,971 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 10,599 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | A | 86,264 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 32,919 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | A | 32,919 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 9,405 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 4,840 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,148 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,310 | 30 | 250,713 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-16 | D | 7,573 | 30 | 229,083 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-17 | D | 14,027 | 32 | 441,851 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-17 | D | 30,040 | 32 | 946,260 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-17 | D | 4,490 | 32 | 141,435 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-18 | D | 55,383 | 35 | 1,943,389 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-18 | D | 23,726 | 35 | 830,410 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | A | 6,376 | 5 | 31,944 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 6,376 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 18,197 | 34 | 619,217 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 36 | 261,351 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 32 | 229,168 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 13,157 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-12 | — | 1,583 | — | — | 3 insiders, 3 accrual rows | ||
| David Wells | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-12 | A | 1,200,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 11,482 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 78,859 | 28 | 2,219,881 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 21,500 | 28 | 605,225 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-14 | — | 2,977 | — | — | 4 insiders, 4 accrual rows | ||
| Irene Becklund | PAO | 2026-08-14 | D | 4,066 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 47,702 | 28 | 1,342,811 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 35,447 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 11,757 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 36,437 | 28 | 1,025,702 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 6,490 | 28 | 182,694 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 100,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | A | 188,285 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | A | 32,920 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | A | 154,993 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 25,927 | — | — | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-14 | A | 545 | — | — | RSU | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 3,880 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 4,345 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | A | 13,685 | — | — | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 64,771 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 95,798 | 28 | 2,696,714 | Common | Form 4 ↗ |
| David Wells | Director | 2026-08-14 | A | 778 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 32,920 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 10,600 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | A | 86,265 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 19,151 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 9,406 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 4,839 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 8,149 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 10,201 | 28 | 287,158 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 260 | — | — | Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | D | 6,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | A | 6,623 | — | — | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 16,147 | 28 | 454,538 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 28 | 261,802 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | A | 9,388 | 5 | 47,034 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-18 | D | 16,773 | 28 | 467,128 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 30 | 148,111 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | A | 4,938 | 5 | 24,739 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-19 | D | 25,111 | 28 | 691,808 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-25 | D | 463,289 | 0 | 0 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-27 | D | 977,566 | 0 | 0 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-02 | D | 3,458 | 28 | 97,965 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-09-15 | D | 14,027 | 28 | 398,227 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-09-15 | D | 7,954 | 28 | 225,814 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-16 | D | 6,236 | 28 | 173,735 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-17 | D | 12,313 | 29 | 354,861 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 14,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 29,277 | 30 | 876,846 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | A | 14,000 | 5 | 70,140 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-30 | D | 3,461 | 29 | 100,957 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-10-01 | D | 2,000 | 30 | 59,400 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-10-14 | D | 3,461 | 29 | 100,577 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | $24 | $187,916 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | A | 7,950 | 5 | 39,830 | Common | Form 4 ↗ |
| Patrick Carroll | Director | 2026-05-20 | A | 435 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-05-20 | A | 957 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-05-20 | A | 647 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-05-26 | A | 48,400 | 24 | 1,172,974 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-06-15 | D | 957 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 435 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 47,699 | 30 | 1,439,079 | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | D | 647 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 11,756 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 6,183 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 23,315 | 30 | 703,414 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 11,483 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,334 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 39,541 | 30 | 1,192,952 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 25,926 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 15,396 | 30 | 464,497 | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 647 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 435 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-15 | A | 957 | — | — | RSU | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 23,513 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 259,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 151,534 | 30 | 4,571,781 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | A | 282,597 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 19,150 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 35,446 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 85,632 | 30 | 2,583,517 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | A | 154,991 | — | — | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 3,879 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 1,392 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,344 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,065 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 2,291 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 5,870 | 30 | 177,098 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | A | 15,971 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 10,599 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | A | 86,264 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 32,919 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | A | 32,919 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 9,405 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 4,840 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,148 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,310 | 30 | 250,713 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-16 | D | 7,573 | 30 | 229,083 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-17 | D | 14,027 | 32 | 441,851 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-17 | D | 30,040 | 32 | 946,260 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-17 | D | 4,490 | 32 | 141,435 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-18 | D | 55,383 | 35 | 1,943,389 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-18 | D | 23,726 | 35 | 830,410 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | A | 6,376 | 5 | 31,944 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 6,376 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 18,197 | 34 | 619,217 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 36 | 261,351 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 32 | 229,168 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 13,157 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-08-12 | A | 778 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-12 | A | 260 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-12 | A | 545 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-12 | A | 1,200,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 11,482 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 78,859 | 28 | 2,219,881 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 21,500 | 28 | 605,225 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 1,394 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 4,066 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 47,702 | 28 | 1,342,811 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 35,447 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 11,757 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 36,437 | 28 | 1,025,702 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 6,490 | 28 | 182,694 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 100,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | A | 188,285 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | A | 32,920 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | A | 154,993 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 25,927 | — | — | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-14 | D | 545 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-14 | A | 545 | — | — | RSU | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 3,880 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 4,345 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | A | 13,685 | — | — | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 64,771 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 95,798 | 28 | 2,696,714 | Common | Form 4 ↗ |
| David Wells | Director | 2026-08-14 | D | 778 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-08-14 | A | 778 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 32,920 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 10,600 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | A | 86,265 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 19,151 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 9,406 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 4,839 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 8,149 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 260 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 10,201 | 28 | 287,158 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 260 | — | — | Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | D | 6,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | A | 6,623 | — | — | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 16,147 | 28 | 454,538 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 28 | 261,802 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | A | 9,388 | 5 | 47,034 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-18 | D | 16,773 | 28 | 467,128 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 30 | 148,111 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | A | 4,938 | 5 | 24,739 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-19 | D | 25,111 | 28 | 691,808 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-25 | D | 463,289 | 0 | 0 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-27 | D | 977,566 | 0 | 0 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-02 | D | 3,458 | 28 | 97,965 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-09-15 | D | 14,027 | 28 | 398,227 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-09-15 | D | 7,954 | 28 | 225,814 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-16 | D | 6,236 | 28 | 173,735 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-17 | D | 12,313 | 29 | 354,861 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 14,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 29,277 | 30 | 876,846 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | A | 14,000 | 5 | 70,140 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-30 | D | 3,461 | 29 | 100,957 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-10-01 | D | 2,000 | 30 | 59,400 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-10-14 | D | 3,461 | 29 | 100,577 | Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Yemi Okupe | RSU | 2024-02-28 | — | — | 183,719 | — | $7,473,689 |
| Nader Kabbani | RSU | 2025-05-19 | — | — | 216,333 | — | 13,486,199 |
| Mohamed Elshenawy | RSU | 2025-05-12 | — | — | 1,036,339 | — | 57,216,276 |
| Yemi Okupe | RSU | 2025-03-03 | — | — | 183,719 | — | 7,473,689 |
| Mike Chi | RSU | 2024-02-28 | — | — | 169,587 | — | 6,898,799 |
| Yemi Okupe | RSU | — | — | — | 183,719 | — | 7,473,689 |
| Mike Chi | RSU | — | — | — | 169,587 | — | 6,898,799 |
| Andrew Dudum | RSU | 2025-03-11 | — | — | 306,406 | — | 10,635,352 |
| Mike Chi | RSU | 2025-03-03 | — | — | 169,587 | — | 6,898,799 |
| Melissa Baird | RSU | 2025-03-03 | — | — | 197,851 | — | 8,048,579 |
| Soleil Boughton | RSU | 2025-03-03 | — | — | 98,925 | — | 4,024,269 |
| Andrew Dudum | OPTION | 2025-03-11 | 278,622 | 557,244 | — | 1,393,110 | 11,000,000 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Yemi Okupe | $22,421,067 | $0 | $0 | 0.0% |
| Nader Kabbani | 13,486,199 | 0 | 0 | 0.0% |
| Mohamed Elshenawy | 57,216,276 | 0 | 0 | 0.0% |
| Mike Chi | 20,696,397 | 0 | 0 | 0.0% |
| Andrew Dudum | 10,635,352 | 0 | 11,000,000 | 0.0% |
| Melissa Baird | 8,048,579 | 0 | 0 | 0.0% |
| Soleil Boughton | 4,024,269 | 0 | 0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Soleil Boughton | RSU | 108,891 | — | $3,535,691 |
| Andrew Dudum | RSU | 670,769 | — | 21,779,869 |
| Nader Kabbani | RSU | 216,333 | — | 7,024,333 |
| Andrew Dudum | PSU | 511,061 | — | 16,594,151 |
| Yemi Okupe | PSU | 205,345 | — | 6,667,552 |
| Mohamed Elshenawy | RSU | 1,036,339 | — | 33,649,927 |
| Andrew Dudum | PSU | 397,001 | — | 12,890,622 |
| Andrew Dudum | RSU | 248,955 | — | 8,083,569 |
| Melissa Baird | RSU | 235,205 | — | 7,637,106 |
| Yemi Okupe | RSU | 206,893 | — | 6,717,816 |
| Mike Chi | PSU | 182,529 | — | 5,926,717 |
| Melissa Baird | PSU | 182,529 | — | 5,926,717 |
| Mike Chi | RSU | 49,487 | — | 1,606,843 |
| Andrew Dudum | RSU | 177,233 | — | 5,754,756 |
| Mike Chi | RSU | 174,226 | — | 5,657,118 |
| Melissa Baird | RSU | 160,754 | — | 5,219,682 |
| Yemi Okupe | PSU | 157,632 | — | 5,118,311 |
| Yemi Okupe | RSU | 149,272 | — | 4,846,862 |
| Mike Chi | RSU | 137,790 | — | 4,474,041 |
| Soleil Boughton | PSU | 136,897 | — | 4,445,046 |
| Mike Chi | PSU | 132,743 | — | 4,310,165 |
| Yemi Okupe | RSU | 91,672 | — | 2,976,590 |
| Soleil Boughton | PSU | 82,964 | — | 2,693,841 |
| Mike Chi | RSU | 81,487 | — | 2,645,883 |
| Melissa Baird | RSU | 81,487 | — | 2,645,883 |
| Soleil Boughton | RSU | 80,377 | — | 2,609,841 |
| Soleil Boughton | RSU | 10,916 | — | 354,443 |
| Soleil Boughton | RSU | 61,115 | — | 1,984,404 |
| Yemi Okupe | RSU | 52,396 | — | 1,701,298 |
| Andrew Dudum | RSU | 35,242 | — | 1,144,308 |
| Melissa Baird | RSU | 18,713 | — | 607,611 |
| Mike Chi | RSU | 9,357 | — | 303,822 |
| Andrew Dudum | Option | 43,451 | 5.01 | — |
| Andrew Dudum | Option | 67,020 | 11.53 | — |
| Yemi Okupe | Option | 21,486 | 5.01 | — |
| Yemi Okupe | Option | 34,665 | 11.53 | — |
| Mike Chi | Option | 34,608 | 5.01 | — |
| Mike Chi | Option | 58,072 | 6.82 | — |
| Mike Chi | Option | 30,814 | 11.53 | — |
| Soleil Boughton | Option | 40,376 | 5.01 | — |
| Soleil Boughton | Option | 23,110 | 11.53 | — |
| Melissa Baird | Option | 69,215 | 5.01 | — |
| Melissa Baird | Option | 30,814 | 11.53 | — |
Our executive compensation programs are designed to attract, reward and retain our named executive officers, who are vital to the success of our Company. Our programs reward our named executive officers for achieving specific annual and strategic goals.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia, Inc. |
| Clawback policy | true |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-11 | 1,506,477,171 | 11,181,420 | 309,881 | 99.26% | Passed |
| 2025 | 2025-06-12 | 1,528,328,634 | 26,472,285 | 309,795 | 98.3% | Passed |
| 2024 | 2024-06-06 | 1,517,206,862 | 42,457,770 | 671,873 | 97.28% | Passed |
| 2023 | 2023-06-01 | 1,529,000,617 | 16,445,485 | 436,802 | 98.94% | Passed |
| 2022 | 2022-06-02 | 1,525,451,481 | 3,204,466 | 725,386 | 99.79% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-11 | 99.26%a |
| 2025 | 2025-06-12 | 98.3%b |
| 2024 | 2024-06-06 | 97.28%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will be counted as present for purposes of determining the presence of a quorum but will not be considered as votes cast for or against this proposal and will therefore have no effect on the outcome of the vote.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will be counted as present for purposes of determining the presence of a quorum but will not be considered as votes cast for or against this proposal and will therefore have no effect on the outcome of the vote.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will be counted as present for purposes of determining the presence of a quorum but will not be considered as votes cast for or against this proposal and will therefore have no effect on the outcome of the vote.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 272 : 1 |
|---|---|
| CEO total compensation | $22,958,907 |
| Median employee compensation | $84,402 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Deb AutorIndependent · Audit · Compensation · Nominating/Governance · Partial-year service | $44,000 | $186,931 | $0 | $0 | $75,000 | $305,931 |
| David WellsIndependent · Lead Independent Director · Audit · Compensation · Nominating/Governance | 87,648 | 186,931 | 0 | 0 | 0 | 274,579 |
| Christopher PayneIndependent · Audit · Compensation · Nominating/Governance | 59,148 | 186,931 | 0 | 0 | 0 | 246,079 |
| Andrea PerezIndependent · Audit (Chair) · Compensation · Nominating/Governance | 55,000 | 186,931 | 0 | 0 | 0 | 241,931 |
| Anja ManuelIndependent · Audit · Compensation (Chair) · Nominating/Governance | 54,000 | 186,931 | 0 | 0 | 0 | 240,931 |
| Christiane PendarvisIndependent · Audit · Compensation · Nominating/Governance (Chair) · Not standing for re-election · Departed during FY | 50,000 | 186,931 | 0 | 0 | 0 | 236,931 |
| Kåre SchultzIndependent · Audit · Compensation · Nominating/Governance · Partial-year service | 44,000 | 186,931 | 0 | 0 | 0 | 230,931 |
| Delos CosgroveIndependent · Audit · Compensation · Nominating/Governance | 40,000 | 186,931 | 0 | 0 | 0 | 226,931 |
| Patrick CarrollNot independent · Audit · Compensation · Nominating/Governance · Not standing for re-election · Departed during FY | 40,000 | 186,931 | 0 | — | 0 | 226,931 |
| Andrew DudumEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| Kofi Amoo-GottfriedIndependent · Audit · Compensation · Nominating/Governance · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 8,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $473,796 |
| Equity awards (grant-date value) | $1,682,379 |
| All other compensation | $75,000 |
| Total cost of the board | $2,231,175 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Hims & Hers Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Hims & Hers Health.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Alteryx | 2022 | Mark Anderson | $650,000 | $55,823,051 | $0 | $650,000 | $57,191,521 |
| 2 | Elastic N.V. | 2026 | Ashutosh Kulkarni | 750,000 | 45,343,687 | 0 | 832,532 | 46,961,904 |
| 3 | Coursera | 2025 | Gregory Hart | 540,833 | 14,629,466 | 23,644,105 | 570,467 | 39,387,371 |
| 4 | Hims & Hers Health | 2025 | Andrew Dudum | 494,792 | 10,635,352 | 11,000,000 | 585,763 | 22,958,907 |
| 5 | Five9 | 2025 | Michael Burkland | 585,000 | 16,186,638 | 0 | 621,270 | 17,403,709 |
| 6 | PagerDuty | 2026 | Jennifer Tejada | 600,000 | 14,219,766 | 0 | 347,760 | 15,268,028 |
| 7 | Privia Health Group | 2025 | Parth Mehrotra | 650,000 | 8,588,373 | 0 | 1,218,750 | 10,472,698 |
| 8 | Yelp | 2025 | Jeremy Stoppelman | 620,000 | 9,104,111 | 0 | 500,444 | 10,256,932 |
| 9 | Smartsheet | 2024 | Mark P. Mader | 587,077 | 9,085,222 | 0 | 511,134 | 10,205,886 |
| 10 | Rapid7 | 2025 | Corey Thomas | 545,000 | 9,195,576 | 0 | 315,000 | 10,058,576 |
| 11 | CarGurus | 2025 | Jason Trevisan | 647,500 | 6,499,975 | 0 | 709,325 | 7,889,260 |
| 12 | Bumble | 2025 | Whitney Wolfe Herd | 650,000 | 6,303,827 | 0 | 650,000 | 7,617,828 |
| 13 | Jamf Holding | 2024 | John Strosahl | 550,001 | 5,999,997 | 0 | 539,000 | 7,106,371 |
| 14 | Udemy | 2024 | Greg Brown | 583,750 | 4,548,838 | 0 | 0 | 5,151,396 |
| 15 | Sprinklr | 2026 | Rory Read | 675,000 | 0 | 0 | 985,500 | 1,664,700 |
| 16 | DigitalOcean | 2025 | Padmanabhan Srinivasan | 600,000 | 0 | 0 | 588,000 | 1,210,795 |
| 17 | EngageSmart | 2022 | Robert Bennett | 600,000 | 0 | 0 | 357,000 | 958,500 |
| 18 | Duolingo | 2025 | Luis von Ahn | 750,000 | 0 | 0 | 0 | 767,500 |
| 19 | Box | 2026 | Aaron Levie | 162,000 | 0 | 0 | 94,912 | 257,076 |
| — | SentinelOne | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Hims & Hers Health | 93.72% | Options 51 · RSU 49 | No | Compensia, Inc. |
| Alteryx | 100% | RSU 75 · PSU 25 | No | Alpine Rewards |
| Box | 105.5% | RSU 50 · PSU 50 | not disclosed | Compensia |
| Bumble | not disclosed | RSU 100 | not disclosed | Semler Brossy |
| CarGurus | 108.29% | RSU 100 | not disclosed | Compensia, Inc. |
| Coursera | 106.3% | not disclosed | No | Compensia, Inc. |
| DigitalOcean | 98% | PSU 65 · RSU 35 | No | Compensia |
| Duolingo | not disclosed | PSU 100 | No | Compensia, Inc. |
| Elastic N.V. | not disclosed | PSU 50 · RSU 50 | No | Semler Brossy Consulting Group LLC |
| EngageSmart | not disclosed | not disclosed | not disclosed | Compensia, Inc. |
| Five9 | 106% | RSU 50 · PSU 50 | Yes — Relative Total Shareholder Return (RTSR) versus the companies of the S&P Software and Services Select Index | Compensia |
| Jamf Holding | not disclosed | RSU 100 | not disclosed | Radford |
| PagerDuty | 58.0% | PSU 50 · RSU 50 | No | Compensia, Inc. |
| Privia Health Group | 150% | PSU 60 · RSU 40 | No | Korn Ferry (through September 2025), WTW (starting September 2025) |
| Rapid7 | 50% | RSU 50 · PSU 50 | No | Compensia |
| SentinelOne | 96% | RSU 60 · PSU 40 | No | Aon |
| Smartsheet | 87.4% | PSU 50 · RSU 50 | No | Compensia |
| Sprinklr | 146.7% | RSU 75 · PSU 25 | Yes — Relative Total Stockholder Return (rTSR) | Compensia |
| Udemy | not disclosed | RSU 50 · PSU 50 | No | FW Cook |
| Yelp | 100.9% | not disclosed | Yes — Relative TSR vs Russell 2000 | Compensia, Inc. |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Mohamed Elshenawy | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “2025 Summary Compensation Table”. As printed: 60,869,746. Filing ↗machine: r9 · c27 · span 605780–605790 |
| 2 | Section 01, Andrew Dudum | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “2025 Summary Compensation Table”. As printed: 22,958,907. Filing ↗machine: r3 · c27 · span 587953–587963 |
| 3 | Section 01, Nader Kabbani | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “2025 Summary Compensation Table”. As printed: 14,862,305. Filing ↗machine: r19 · c27 · span 636775–636785 |
| 4 | Section 01, Yemi Okupe | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “2025 Summary Compensation Table”. As printed: 8,398,808. Filing ↗machine: r6 · c27 · span 596859–596868 |
| 5 | Section 01, Melissa Baird | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “2025 Summary Compensation Table”. As printed: 8,392,871. Filing ↗machine: r16 · c27 · span 627291–627300 |
| 6 | Section 01, Mike Chi | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “2025 Summary Compensation Table”. As printed: 7,727,713. Filing ↗machine: r10 · c27 · span 609141–609150 |
| 7 | Section 01, Soleil Boughton | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “2025 Summary Compensation Table”. As printed: 4,796,709. Filing ↗machine: r13 · c27 · span 618094–618103 |
| 8 | Section 03, Yemi Okupe RSU | DEF 14A | — | — | Section “Executive Compensation” · grants of plan-based awards table. |
| 9 | Section 03, Nader Kabbani RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t96 · r16 · c13 · span 678628–678638 |
| 10 | Section 03, Mohamed Elshenawy RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t96 · r9 · c13 · span 664522–664532 |
| 11 | Section 03, Yemi Okupe RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 660656–660665 |
| 12 | Section 03, Mike Chi RSU | DEF 14A | — | — | Section “Executive Compensation” · grants of plan-based awards table. |
| 13 | Section 03, Yemi Okupe RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t96 · r7 · c13 · span 660656–660665 |
| 14 | Section 03, Mike Chi RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t96 · r11 · c13 · span 668379–668388 |
| 15 | Section 03, Andrew Dudum RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 654221–654231 |
| 16 | Section 03, Mike Chi RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 668379–668388 |
| 17 | Section 03, Melissa Baird RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 676053–676062 |
| 18 | Section 03, Soleil Boughton RSU | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 672239–672248 |
| 19 | Section 03, Andrew Dudum OPTION | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 656795–656805 |
| 20 | Section 07, pay ratio | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “CEO Pay Ratio”. As printed: 272 : 1. Filing ↗machine: span 1047031–1047034 |
| 21 | Section 08, Deb Autor | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 305,931. Filing ↗machine: span 903432–903644 |
| 22 | Section 08, David Wells | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 274,579. Filing ↗machine: span 917742–918021 |
| 23 | Section 08, Christopher Payne | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 246,079. Filing ↗machine: span 910421–910665 |
| 24 | Section 08, Andrea Perez | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 241,931. Filing ↗machine: span 913947–914191 |
| 25 | Section 08, Anja Manuel | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 240,931. Filing ↗machine: span 908657–908901 |
| 26 | Section 08, Christiane Pendarvis | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 236,931. Filing ↗machine: span 912188–912432 |
| 27 | Section 08, Kåre Schultz | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 230,931. Filing ↗machine: span 915739–915983 |
| 28 | Section 08, Delos Cosgrove | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 226,931. Filing ↗machine: span 906899–907143 |
| 29 | Section 08, Patrick Carroll | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 226,931. Filing ↗machine: span 905132–905376 |
| 30 | Section 08, Andrew Dudum | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 31 | Section 08, Kofi Amoo-Gottfried | DEF 14A | 2026-04-28 | 0001773751-26-000060 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 32 | Section 02, Yemi Okupe 2026-05-18 | Form 4 | 2026-05-19 | 0001773751-26-000078 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Yemi Okupe 2026-05-18 | Form 4 | 2026-05-19 | 0001773751-26-000078 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Yemi Okupe 2026-05-18 | Form 4 | 2026-05-19 | 0001773751-26-000078 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Patrick Carroll 2026-05-20 | Form 4 | 2026-05-22 | 0001773751-26-000084 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, David Wells 2026-05-20 | Form 4 | 2026-05-22 | 0001773751-26-000082 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Christopher Payne 2026-05-20 | Form 4 | 2026-05-22 | 0001773751-26-000083 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, David Wells 2026-05-26 | Form 4 | 2026-05-26 | 0001773751-26-000086 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Deb Autor 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000112 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Delos Cosgrove 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000107 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Delos Cosgrove 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000107 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Anja Manuel 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000108 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Anja Manuel 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000108 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Christiane Pendarvis 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000109 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Christiane Pendarvis 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000109 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Christopher Payne 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000110 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Christopher Payne 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000110 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Deb Autor 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000112 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Patrick Carroll 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000113 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Patrick Carroll 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000113 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Andrea Perez 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000114 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Andrea Perez 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000114 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Kåre Schultz 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000115 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Kåre Schultz 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000115 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, David Wells 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000116 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, David Wells 2026-06-11 | Form 4 | 2026-06-15 | 0001773751-26-000116 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Anja Manuel 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000108 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, David Wells 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000116 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000113 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Mike Chi 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Christopher Payne 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000110 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Soleil Boughton 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000127 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Soleil Boughton 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000127 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Soleil Boughton 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000127 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Soleil Boughton 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000127 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Soleil Boughton 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000127 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Soleil Boughton 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000127 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Yemi Okupe 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Yemi Okupe 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Yemi Okupe 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Yemi Okupe 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Yemi Okupe 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Yemi Okupe 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Anja Manuel 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000108 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Andrew Dudum 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Deb Autor 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000130 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Christopher Payne 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000110 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Christopher Payne 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000110 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Christopher Payne 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000110 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000113 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, David Wells 2026-06-15 | Form 4 | 2026-06-15 | 0001773751-26-000116 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Mohamed Elshenawy 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Mohamed Elshenawy 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Mohamed Elshenawy 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Mohamed Elshenawy 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Andrew Dudum 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Andrew Dudum 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Andrew Dudum 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Andrew Dudum 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Andrew Dudum 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Irene Becklund 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Irene Becklund 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Irene Becklund 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Irene Becklund 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Irene Becklund 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Irene Becklund 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Irene Becklund 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Mike Chi 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Mike Chi 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Mike Chi 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Mike Chi 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, Mike Chi 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, Mike Chi 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, Deb Autor 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000130 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Deb Autor 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000130 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 111 | Section 02, Patrick Carroll 2026-06-15 | Form 4 | 2026-06-17 | 0001773751-26-000132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 112 | Section 02, Irene Becklund 2026-06-16 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 113 | Section 02, Mike Chi 2026-06-17 | Form 4 | 2026-06-17 | 0001773751-26-000129 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 114 | Section 02, Mohamed Elshenawy 2026-06-17 | Form 4 | 2026-06-17 | 0001773751-26-000125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 115 | Section 02, Irene Becklund 2026-06-17 | Form 4 | 2026-06-17 | 0001773751-26-000128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 116 | Section 02, Yemi Okupe 2026-06-18 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 117 | Section 02, Patrick Carroll 2026-06-18 | Form 4 | 2026-06-23 | 0001773751-26-000136 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 118 | Section 02, Yemi Okupe 2026-06-22 | Form 4 | 2026-06-23 | 0001773751-26-000135 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 119 | Section 02, Yemi Okupe 2026-06-22 | Form 4 | 2026-06-23 | 0001773751-26-000135 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 120 | Section 02, Yemi Okupe 2026-06-22 | Form 4 | 2026-06-23 | 0001773751-26-000135 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 121 | Section 02, Yemi Okupe 2026-07-06 | Form 4 | 2026-07-07 | 0001907056-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 122 | Section 02, Yemi Okupe 2026-07-06 | Form 4 | 2026-07-07 | 0001907056-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 123 | Section 02, Yemi Okupe 2026-07-06 | Form 4 | 2026-07-07 | 0001907056-26-000018 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 124 | Section 02, Yemi Okupe 2026-07-17 | Form 4 | 2026-07-20 | 0001907056-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 125 | Section 02, Yemi Okupe 2026-07-17 | Form 4 | 2026-07-20 | 0001907056-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 126 | Section 02, Yemi Okupe 2026-07-17 | Form 4 | 2026-07-20 | 0001907056-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 127 | Section 02, Kofi Amoo-Gottfried 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000184 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 128 | Section 02, Kofi Amoo-Gottfried 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000184 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 129 | Section 02, David Wells 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000185 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 130 | Section 02, David Wells 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000185 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 131 | Section 02, Patrick Carroll 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000186 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 132 | Section 02, Deb Autor 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000187 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 133 | Section 02, Delos Cosgrove 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000188 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 134 | Section 02, Anja Manuel 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000189 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 135 | Section 02, Andrea Perez 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000190 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 136 | Section 02, Christopher Payne 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000191 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 137 | Section 02, Christopher Payne 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000191 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 138 | Section 02, Kåre Schultz 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000192 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 139 | Section 02, Mohamed Elshenawy 2026-08-12 | Form 4 | 2026-08-14 | 0001773751-26-000193 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 140 | Section 02, Yemi Okupe 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 141 | Section 02, Yemi Okupe 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 142 | Section 02, Andrew Dudum 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000212 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 143 | Section 02, Soleil Boughton 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000215 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 144 | Section 02, Soleil Boughton 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000215 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 145 | Section 02, Irene Becklund 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000206 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 146 | Section 02, Irene Becklund 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000206 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 147 | Section 02, Mohamed Elshenawy 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000207 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 148 | Section 02, Mike Chi 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 149 | Section 02, Mike Chi 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 150 | Section 02, Andrew Dudum 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000212 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 151 | Section 02, Soleil Boughton 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000215 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 152 | Section 02, Soleil Boughton 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000215 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 153 | Section 02, Soleil Boughton 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000215 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 154 | Section 02, Yemi Okupe 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 155 | Section 02, Yemi Okupe 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 156 | Section 02, Yemi Okupe 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 157 | Section 02, Irene Becklund 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000206 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 158 | Section 02, Mohamed Elshenawy 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000207 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 159 | Section 02, Mohamed Elshenawy 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000207 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 160 | Section 02, Deb Autor 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000209 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 161 | Section 02, Mike Chi 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 162 | Section 02, Andrew Dudum 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000212 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 163 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 164 | Section 02, Christopher Payne 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000205 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 165 | Section 02, Christopher Payne 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000205 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 166 | Section 02, Irene Becklund 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000206 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 167 | Section 02, Irene Becklund 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000206 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 168 | Section 02, Irene Becklund 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000206 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 169 | Section 02, Mohamed Elshenawy 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000207 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 170 | Section 02, Mohamed Elshenawy 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000207 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 171 | Section 02, David Wells 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000208 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 172 | Section 02, David Wells 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000208 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 173 | Section 02, Deb Autor 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000209 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 174 | Section 02, Mike Chi 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 175 | Section 02, Mike Chi 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 176 | Section 02, Mike Chi 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 177 | Section 02, Mike Chi 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 178 | Section 02, Andrew Dudum 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000212 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 179 | Section 02, Andrew Dudum 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000212 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 180 | Section 02, Andrew Dudum 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000212 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 181 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 182 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 183 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 184 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 185 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 186 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 187 | Section 02, Patrick Carroll 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 188 | Section 02, Kåre Schultz 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000214 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 189 | Section 02, Kåre Schultz 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000214 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 190 | Section 02, Soleil Boughton 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000215 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 191 | Section 02, Deb Autor 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000209 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 192 | Section 02, Yemi Okupe 2026-08-14 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 193 | Section 02, Yemi Okupe 2026-08-17 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 194 | Section 02, Yemi Okupe 2026-08-17 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 195 | Section 02, Yemi Okupe 2026-08-17 | Form 4 | 2026-08-18 | 0001773751-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 196 | Section 02, Deb Autor 2026-08-18 | Form 4 | 2026-08-20 | 0001884671-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 197 | Section 02, Yemi Okupe 2026-08-19 | Form 4 | 2026-08-20 | 0001907056-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 198 | Section 02, Yemi Okupe 2026-08-19 | Form 4 | 2026-08-20 | 0001907056-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 199 | Section 02, Yemi Okupe 2026-08-19 | Form 4 | 2026-08-20 | 0001907056-26-000022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 200 | Section 02, Soleil Boughton 2026-08-19 | Form 4 | 2026-08-20 | 0001837817-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 201 | Section 02, Andrew Dudum 2026-08-25 | Form 4 | 2026-08-27 | 0001773751-26-000217 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 202 | Section 02, Andrew Dudum 2026-08-27 | Form 4 | 2026-08-27 | 0001773751-26-000217 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 203 | Section 02, Soleil Boughton 2026-09-02 | Form 4 | 2026-09-03 | 0001837817-26-000013 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 204 | Section 02, Mike Chi 2026-09-15 | Form 4 | 2026-09-17 | 0001965903-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 205 | Section 02, Mohamed Elshenawy 2026-09-15 | Form 4 | 2026-09-17 | 0002068597-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 206 | Section 02, Soleil Boughton 2026-09-16 | Form 4 | 2026-09-17 | 0001837817-26-000015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 207 | Section 02, Yemi Okupe 2026-09-17 | Form 4 | 2026-09-18 | 0001907056-26-000024 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 208 | Section 02, Yemi Okupe 2026-09-22 | Form 4 | 2026-09-23 | 0001907056-26-000026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 209 | Section 02, Yemi Okupe 2026-09-22 | Form 4 | 2026-09-23 | 0001907056-26-000026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 210 | Section 02, Yemi Okupe 2026-09-22 | Form 4 | 2026-09-23 | 0001907056-26-000026 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 211 | Section 02, Soleil Boughton 2026-09-30 | Form 4 | 2026-10-02 | 0001837817-26-000017 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 212 | Section 02, Yemi Okupe 2026-10-01 | Form 4 | 2026-10-02 | 0001907056-26-000028 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 213 | Section 02, Soleil Boughton 2026-10-14 | Form 4 | 2026-10-15 | 0001773751-26-000227 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 214 | Section 06, 2026 vote | Form 8-K | 2026-06-15 | 0001773751-26-000096 | Item 5.07 · say-on-pay result. As reported: 99.26% (votes for as printed: 1,506,477,171). Filing ↗ |
| 215 | Section 06, 2025 vote | Form 8-K | 2025-06-17 | 0001773751-25-000211 | Item 5.07 · say-on-pay result. As reported: 98.3% (votes for as printed: 1,528,328,634). Filing ↗ |
| 216 | Section 06, 2024 vote | Form 8-K | 2024-06-10 | 0001773751-24-000185 | Item 5.07 · say-on-pay result. As reported: 97.28% (votes for as printed: 1,517,206,862). Filing ↗ |
| 217 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 218 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 219 | Section 09b board cost (computed) | Computed | — | — | Cash 473,796 + equity 1,682,379 + all other 75,000 = 2,231,175, summed across the director compensation table rows.machine: formula: Σ = 2,231,175 |
| 220 | Alteryx, Section 10b CEO total | DEF 14A | 2023-04-04 | 0001140361-23-016229 | CEO total compensation as printed in Alteryx's own proxy. As printed: 57,191,521. Filing ↗machine: r1 · c24 · span 1147355–1147365 |
| 221 | Elastic N.V., Section 10b CEO total | DEF 14A | 2026-08-28 | 0001707753-26-000055 | CEO total compensation as printed in Elastic N.V.'s own proxy. As printed: 46,961,904. Filing ↗machine: span 823226–823236 |
| 222 | Coursera, Section 10b CEO total | DEF 14A | 2026-05-11 | 0001651562-26-000036 | CEO total compensation as printed in Coursera's own proxy. As printed: 39,387,371. Filing ↗machine: r3 · c33 · span 735414–735424 |
| 223 | Hims & Hers Health (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001773751-26-000060 | CEO total compensation as printed in Hims & Hers Health's own proxy. As printed: 22,958,907. Filing ↗machine: r3 · c27 · span 587953–587963 |
| 224 | Five9, Section 10b CEO total | DEF 14A | 2026-04-07 | 0001288847-26-000055 | CEO total compensation as printed in Five9's own proxy. As printed: 17,403,709. Filing ↗machine: r4 · c24 · span 919196–919206 |
| 225 | PagerDuty, Section 10b CEO total | DEF 14A | 2026-05-04 | 0001568100-26-000020 | CEO total compensation as printed in PagerDuty's own proxy. As printed: 15,268,028. Filing ↗machine: r4 · c45 · span 603528–603538 |
| 226 | Privia Health Group, Section 10b CEO total | DEF 14A | 2026-04-02 | 0001193125-26-138997 | CEO total compensation as printed in Privia Health Group's own proxy. As printed: 10,472,698. Filing ↗machine: t166 · r3 · c39 · span 538905–538915 |
| 227 | Yelp, Section 10b CEO total | DEF 14A | 2026-04-17 | 0001345016-26-000027 | CEO total compensation as printed in Yelp's own proxy. As printed: 10,256,932. Filing ↗machine: r4 · c21 · span 951856–951866 |
| 228 | Smartsheet, Section 10b CEO total | DEF 14A | 2024-05-01 | 0001366561-24-000093 | CEO total compensation as printed in Smartsheet's own proxy. As printed: 10,205,886. Filing ↗machine: r2 · c48 · span 623515–623525 |
| 229 | Rapid7, Section 10b CEO total | DEF 14A | 2026-04-22 | 0001560327-26-000019 | CEO total compensation as printed in Rapid7's own proxy. As printed: 10,058,576. Filing ↗machine: r2 · c42 · span 505425–505435 |
| 230 | CarGurus, Section 10b CEO total | DEF 14A | 2026-04-22 | 0001193125-26-170400 | CEO total compensation as printed in CarGurus's own proxy. As printed: 7,889,260. Filing ↗machine: r2 · c7 · span 953842–953851 |
| 231 | Bumble, Section 10b CEO total | DEF 14A | 2026-04-17 | 0001628280-26-025680 | CEO total compensation as printed in Bumble's own proxy. As printed: 7,617,828. Filing ↗machine: r5 · c23 · span 1317195–1317204 |
| 232 | Jamf Holding, Section 10b CEO total | DEF 14A | 2025-04-29 | 0001104659-25-041308 | CEO total compensation as printed in Jamf Holding's own proxy. As printed: 7,106,371. Filing ↗machine: span 429483–429492 |
| 233 | Udemy, Section 10b CEO total | DEF 14A | 2025-04-25 | 0001607939-25-000046 | CEO total compensation as printed in Udemy's own proxy. As printed: 5,151,396. Filing ↗machine: r2 · c42 · span 749913–749922 |
| 234 | Sprinklr, Section 10b CEO total | DEF 14A | 2026-05-01 | 0001140361-26-018552 | CEO total compensation as printed in Sprinklr's own proxy. As printed: 1,664,700. Filing ↗machine: r2 · c21 · span 559209–559218 |
| 235 | DigitalOcean, Section 10b CEO total | DEF 14A | 2026-04-24 | 0001582961-26-000029 | CEO total compensation as printed in DigitalOcean's own proxy. As printed: 1,210,795. Filing ↗machine: r2 · c42 · span 468499–468508 |
| 236 | EngageSmart, Section 10b CEO total | DEF 14A | 2023-04-05 | 0000950170-23-011925 | CEO total compensation as printed in EngageSmart's own proxy. As printed: 958,500. Filing ↗machine: r2 · c7 · span 466903–466910 |
| 237 | Duolingo, Section 10b CEO total | DEF 14A | 2026-04-17 | 0001628280-26-025728 | CEO total compensation as printed in Duolingo's own proxy. As printed: 767,500. Filing ↗machine: t83 · r3 · c8 · span 569993–570000 |
| 238 | Box, Section 10b CEO total | DEF 14A | 2026-05-13 | 0001140361-26-021041 | CEO total compensation as printed in Box's own proxy. As printed: 257,076. Filing ↗machine: t245 · r2 · c22 · span 1212030–1212037 |
| 239 | Section 10a, Privia Health Group reciprocity | DEF 14A | — | 0001193125-26-138997 | Privia Health Group's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 240 | Section 10a, Smartsheet reciprocity | DEF 14A | — | 0001366561-24-000093 | Smartsheet's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 241 | Section 10a, Coursera reciprocity | DEF 14A | — | 0001651562-26-000036 | Coursera's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 242 | Section 10a, Bumble reciprocity | DEF 14A | — | 0001628280-26-025680 | Bumble's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 243 | Section 10a, Udemy reciprocity | DEF 14A | — | 0001607939-25-000046 | Udemy's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 244 | Section 10a, Alteryx reciprocity | DEF 14A | — | 0001140361-23-016229 | Alteryx's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 245 | Section 10a, Box reciprocity | DEF 14A | — | 0001140361-26-021041 | Box's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 246 | Section 10a, Duolingo reciprocity | DEF 14A | — | 0001628280-26-025728 | Duolingo's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 247 | Section 10a, Elastic N.V. reciprocity | DEF 14A | — | 0001707753-26-000055 | Elastic N.V.'s most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 248 | Section 10a, Five9 reciprocity | DEF 14A | — | 0001288847-26-000055 | Five9's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 249 | Section 10a, Jamf Holding reciprocity | DEF 14A | — | 0001104659-25-041308 | Jamf Holding's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 250 | Section 10a, PagerDuty reciprocity | DEF 14A | — | 0001568100-26-000020 | PagerDuty's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 251 | Section 10a, Rapid7 reciprocity | DEF 14A | — | 0001560327-26-000019 | Rapid7's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 252 | Section 10a, SentinelOne reciprocity | DEF 14A | — | 0001583708-26-000031 | SentinelOne's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 253 | Section 10a, Sprinklr reciprocity | DEF 14A | — | 0001140361-26-018552 | Sprinklr's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
| 254 | Section 10a, Yelp reciprocity | DEF 14A | — | 0001345016-26-000027 | Yelp's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.